These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 34344430)
1. Five-year overall survival following chemoradiation therapy for locally advanced cervical carcinoma in women living with and without HIV infection in Botswana. MacDuffie E; Bvochora-Nsingo M; Chiyapo S; Balang D; Chambers A; George JM; Tuli S; Lin LL; Zetola NM; Ramogola-Masire D; Grover S Infect Agent Cancer; 2021 Aug; 16(1):55. PubMed ID: 34344430 [TBL] [Abstract][Full Text] [Related]
2. Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting. Grover S; Bvochora-Nsingo M; Yeager A; Chiyapo S; Bhatia R; MacDuffie E; Puri P; Balang D; Ratcliffe S; Narasimhamurthy M; Gwangwava E; Tsietso S; Kayembe MKA; Ramogola-Masire D; Dryden-Peterson S; Mahantshetty U; Viswanathan AN; Zetola NM; Lin LL Int J Radiat Oncol Biol Phys; 2018 May; 101(1):201-210. PubMed ID: 29619965 [TBL] [Abstract][Full Text] [Related]
3. HIV infection is not associated with the initiation of curative treatment in women with cervical cancer in Botswana. Grover S; MacDuffie EC; Wang Q; Bvochora-Nsingo M; Bhatia RK; Balang D; Chiyapo SP; Luckett R; Ramogola-Masire D; Dryden-Peterson SL; Lin LL; Shin SS; Zetola NM Cancer; 2019 May; 125(10):1645-1653. PubMed ID: 30801696 [TBL] [Abstract][Full Text] [Related]
4. Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana. Meghani K; Puri P; Bazzett-Matabele L; Vuylsteke P; Luckett R; Monare B; Chiyapo S; Ketlametswe R; Ralefala TB; Bvochora-Nsingo M; Zetola N; Ramogola-Masire D; Grover S Cancer; 2024 Jul; 130(14):2462-2471. PubMed ID: 38529676 [TBL] [Abstract][Full Text] [Related]
5. Stage and outcomes of invasive cervical cancer patients in Botswana: A prospective cohort study from 2013 to 2020. Grover S; George J; Tuli S; Lichter K; Bhatia R; Monare B; Chinniah G; Bazzett-Matabele L; Bvochora-Nsingo M; Chiyapo S; Balang D; Ralefala T; Vuylsteke P; Luckett R; Shin S; Zetola N; Ramogola-Masire D Gynecol Oncol Rep; 2022 Dec; 44():101094. PubMed ID: 36337265 [TBL] [Abstract][Full Text] [Related]
6. Association Between CD4 Count and Chemoradiation Therapy Outcomes Among Cervical Cancer Patients With HIV. Grover S; Mehta P; Wang Q; Bhatia R; Bvochora-Nsingo M; Davey S; Iyengar M; Shah S; Shin SS; Zetola NM J Acquir Immune Defic Syndr; 2020 Oct; 85(2):201-208. PubMed ID: 32568769 [TBL] [Abstract][Full Text] [Related]
7. Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana. Ramogola-Masire D; Grover S; Mathoma A; Monare B; Gabaitiri L; Bazzett-Matabele L; Hofmeyr G; Morroni C; Luckett R BMC Womens Health; 2022 Apr; 22(1):100. PubMed ID: 35366863 [TBL] [Abstract][Full Text] [Related]
8. Delays in Cervical Cancer Treatment Initiation for Patients Living With or Without HIV in Botswana: An Observational Cohort Analysis (2015-2019). George J; Tuli S; Patel PP; Monare B; Ramogola-Masire D; Bazzett-Matabele L; Bvochora-Nsingo M; Chiyapo S; Ralefala T; Vuylsteke P; Rendle KA; Grover S Int J Radiat Oncol Biol Phys; 2024 Aug; 119(5):1368-1378. PubMed ID: 38462016 [TBL] [Abstract][Full Text] [Related]
9. Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus. Grover S; Ning MS; Bale M; Lichter KE; Shah S; Bvochora-Nsingo M; Chiyapo S; Balang D; McGinnis GJ; Ralefala T; Moloi T; Luckett R; Ramogola-Masire D; Robertson ES; Zetola NM Int J Gynecol Cancer; 2021 Sep; 31(9):1220-1227. PubMed ID: 34312220 [TBL] [Abstract][Full Text] [Related]
10. Impact of HIV infection on overall survival among women with stage IV breast cancer in South Africa. Pumpalova YS; Ayeni OA; Chen WC; O'Neil DS; Nietz S; Phakathi B; Buccimazza I; Čačala S; Stopforth LW; Farrow HA; Joffe M; Mapanga W; Jacobson JS; Crew KD; Cubasch H; Ruff P; Neugut AI Breast Cancer Res Treat; 2021 Aug; 189(1):285-296. PubMed ID: 34125339 [TBL] [Abstract][Full Text] [Related]
11. Vulvar cancer in Botswana in women with and without HIV infection: patterns of treatment and survival outcomes. MacDuffie E; Sakamuri S; Luckett R; Wang Q; Bvochara-Nsingo M; Monare B; Bazzett-Matabele L; Moloi T; Ralefala T; Ramogola-Masire D; Shin SS; Zetola NM; Grover S Int J Gynecol Cancer; 2021 Oct; 31(10):1328-1334. PubMed ID: 34493586 [TBL] [Abstract][Full Text] [Related]
12. Impact of HIV infection on survival among women with stage I-III breast cancer: Results from the South African breast cancer and HIV outcomes study. Ayeni OA; O'Neil DS; Pumpalova YS; Chen WC; Nietz S; Phakathi B; Buccimazza I; Čačala S; Stopforth LW; Farrow HA; Mapanga W; Joffe M; Chirwa T; McCormack V; Jacobson JS; Crew KD; Neugut AI; Ruff P; Cubasch H Int J Cancer; 2022 Jul; 151(2):209-221. PubMed ID: 35218568 [TBL] [Abstract][Full Text] [Related]
13. High-risk human papillomavirus prevalence in self-collected cervicovaginal specimens from human immunodeficiency virus (HIV)-negative women and women living with HIV living in Botswana. Castle PE; Varallo JE; Bertram MM; Ratshaa B; Kitheka M; Rammipi K PLoS One; 2020; 15(2):e0229086. PubMed ID: 32053659 [TBL] [Abstract][Full Text] [Related]
14. Differences in Outcomes of Chemoradiation in Women With Invasive Cervical Cancer by Human Immunodeficiency Virus Status: A Systematic Review. Shah S; Xu M; Mehta P; Zetola NM; Grover S Pract Radiat Oncol; 2021; 11(1):53-65. PubMed ID: 32428763 [TBL] [Abstract][Full Text] [Related]
15. Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2010; 10(4):1-56. PubMed ID: 23074407 [TBL] [Abstract][Full Text] [Related]
16. Predictors of mortality in adults on treatment for human immunodeficiency virus-associated tuberculosis in Botswana: A retrospective cohort study. Muyaya LM; Young T; Loveday M Medicine (Baltimore); 2018 Apr; 97(16):e0486. PubMed ID: 29668628 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis. Farahani M; Vable A; Lebelonyane R; Seipone K; Anderson M; Avalos A; Chadborn T; Tilahun H; Roumis D; Moeti T; Musuka G; Busang L; Gaolathe T; Malefho KC; Marlink R Lancet Glob Health; 2014 Jan; 2(1):e44-50. PubMed ID: 25104635 [TBL] [Abstract][Full Text] [Related]
18. The association between HIV infection and cervical cancer presentation and survival in Uganda. Wu ES; Urban RR; Krantz EM; Mugisha NM; Nakisige C; Schwartz SM; Gray HJ; Casper C Gynecol Oncol Rep; 2020 Feb; 31():100516. PubMed ID: 31886403 [TBL] [Abstract][Full Text] [Related]
19. Impact of HIV infection on baseline characteristics and survival of women with breast cancer. Brandão M; Bruzzone M; Franzoi MA; De Angelis C; Eiger D; Caparica R; Piccart-Gebhart M; Buisseret L; Ceppi M; Dauby N; Carrilho C; Lunet N; de Azambuja E; Lambertini M AIDS; 2021 Mar; 35(4):605-618. PubMed ID: 33394680 [TBL] [Abstract][Full Text] [Related]
20. Five-year overall survival following chemoradiation among HIV-positive and HIV-negative patients with locally advanced cervical carcinoma in a South African cohort. Simonds HM; Botha MH; Neugut AI; Van Der Merwe FH; Jacobson JS Gynecol Oncol; 2018 Nov; 151(2):215-220. PubMed ID: 30194006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]